• Explore /
  • Poster
  • / Loss of body weight during neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil as predictive of poor survival of patients with esophageal squamous cell carcinoma.

Loss of body weight during neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil as predictive of poor survival of patients with esophageal squamous cell carcinoma.

Abstract Poster

Authors

null

Munehiro Ito

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

Munehiro Ito , Ken Kato , Shun Yamamoto , Hiroshi Imazeki , Masahiko Aoki , Kotoe Oshima , Hidekazu Hirano , Natsuko Okita , Hirokazu Shoji , Yoshitaka Honma , Satoru Iwasa , Atsuo Takashima , Jun Kanamori , Junya Oguma , Hiroyuki Daiko , Narikazu Boku

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 371)

Abstract #

371

Poster Bd #

E4

Abstract Disclosures

Similar Posters

First Author: Yusuke Sasaki

First Author: Toshiyasu Ojima

First Author: Jun Okui

First Author: Satoru Matsuda